QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): February 17, 2004

EPIX Medical, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction
of incorporation)
  000-21863
(Commission
File Number)
  04-3030815
(IRS Employer
Identification No.)


71 Rogers Street
Cambridge, Massachusetts 02142
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (617) 250-6000




Item 7. Financial Statements and Exhibits.

(c)
The following exhibits are furnished with this report:

Exhibit Number


 

Description

99.1   Press Release dated February 17, 2004.

Item 9. Regulation FD Disclosure.

        The following information is furnished pursuant to Item 12, "Disclosure of Results of Operations and Financial Conditions."

        On February 17, 2004, the Registrant issued a press release to report its financial results for the full year and the fourth quarter ended December 31, 2003. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.

        In accordance with the procedural guidance in SEC Release No. 33-8216, the information in this Form 8-K and the Exhibit attached to this Form 8-K are being furnished under "Item 9. Regulation FD Disclosure" rather than under "Item 12. Disclosure of Results of Operations and Financial Condition." The information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.




SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    EPIX Medical, Inc.
(Registrant)

Date: February 17, 2004

 

/s/  
PEYTON J. MARSHALL      
Peyton J. Marshall
Senior Vice-President,
Finance and Administration,
Chief Financial Officer



QuickLinks

SIGNATURES